References
- 1. R. S. Herbst, Review of epidermal growth factor receptor biology, Int. J. Radiat. Oncol. Biol. Phys. 59 (2004) 21-26; DOI: 10.1016/j.ijrobp.2003.11.041.
- 2. H. Zhang, A. Berezov, Q. Wang, G. Zhang, J. Drebin, R. Murali and M. I. Greene, ErbB receptors: from oncogenes to targeted cancer therapies, J. Clin. Invest. 117 (2007) 2051-2058; DOI: 10.1172/JCI32278.
- 3. A. Kendall, R. Lord and N. Maisey, Anti-epidermal growth factor receptor antibodies in the treatment of metastatic colorectal cancer, Recent. Pat. Anticancer Drug Discov. 5 (2010) 142-151; DOI: 10. 2174/157489210790936270.
- 4. M. S. Ramakrishnan, A. Eswaraiah, T. Crombet, P. Piedra, G. Saurez, H. Iyer and A. S. Arvind, Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin, mAbs 1 (2009) 41-48; DOI: 10.4161/mabs.1.1.7509.
- 5. R. C. Chatelier, R. G. Ashcroft, C. J. Lloyd, E. C. Nice, R. H. Whitehead, W. H. Sawyer and A.W. Burgess, Binding of fluoresceinated epidermal growth factor to A431 cell sub-populations studied using a model-independent analysis of flow cytometric fluorescence data, EMBO 5 (1986) 1181-1186.
- 6. N. B. S. Abid, Z. Rouis, F. Nefzi, N. Souelah and M. Aouni, Evaluation of dimethylthiazol diphenyl tetrazolium bromide and propidium iodide inclusion assays for the evaluation of cell viability by flow cytometry, J. Appl. Pharm. Sci. 2 (2012) 10-14; DOI: 10.7324/JAPS.2012.2525.
- 7. A. L. Givan, Critical Aspects of Staining for Flow Cytometry, in Living Color: Protocols in Flow Cytometry and Cell Sorting (Eds. R. Diamond and S. DeMaggio), 1st ed., Springer, Berlin 2000, pp. 142-164.
- 8. W. K. Boland and G. Bebb, Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity, Expert Opin. Biol. Ther. 9 (2009) 1-8; DOI: 10.1517/14712590903110709.
- 9. J. M. Reichert, Antibody-based therapeutics to watch in 2011, mAbs 3 (2011) 76-99; DOI: 10.4161/mabs.3.1.13895.
- 10. R. I. Freshney, Basic Principles of Cell Culture, in Culture of Cells for Tissue Engineering (Eds. G. Vunjak-Novakovic and R. I. Freshney), John Wiley, New York 2006, pp. 11-14.
- 11. G. Rothe, Technical Background and Methodological Principles of Flow Cytometry, in Cellular Diagnostics. Basics, Methods and Clinical Applications of Flow Cytometry (Eds. U. Sack, A. Tarnok and G. Rothe), Karger, Basel 2009, pp. 53-88; DOI: 10.1159/000209156.
- 12. G. N. Gill and C. S. Lazar, Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells, Nature 293 (1981) 305-307.
- 13. L. Nikfarjam and P. Farzaneh, Prevention and detection of mycoplasma contamination in cell culture, Cell J. (Yakhteh) 13 (2012) 203-212.
- 14. T. Mammone, D. Gan and R. Foyouzi-Youssefi, Apoptotic cell death increases with senescence in normal human dermal fibroblast cultures, Cell Biol. Int. 30 (2006) 903-909; DOI: 10.1016/j.cellbi.2006.06.010.
- 15. S. Gupta, S. R. Indelicato, V. Jethwa, T. Kawabata, M. Kelley, A. R. Mire-Sluis, S. M. Richards, B. Rup, E. Shores, S. J. Swanson and E. Wakshull, Recommendations for the design optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics, J. Immunol. Met. 321 (2007) 1-18; DOI: 10.1016/j.jim.2004.06.002.